As of 2025-07-14, the Relative Valuation of Lotus Pharmaceutical Co Ltd (1795.TW) is 359.73 TWD. This relative valuation is based on P/E multiples. With the latest stock price at 215.00 TWD, the upside of Lotus Pharmaceutical Co Ltd based on Relative Valuation is 67.3%.
The range of the Relative Valuation is 276.49 - 518.74 TWD.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 19.9x | 17.3x |
| Forward P/E multiples | 12.9x - 24.2x | 17.0x |
| Fair Price | 276.49 - 518.74 | 359.73 |
| Upside | 28.6% - 141.3% | 67.3% |
| Date | P/E |
| 2025-07-10 | 10.41 |
| 2025-07-09 | 10.17 |
| 2025-07-08 | 10.12 |
| 2025-07-07 | 10.41 |
| 2025-07-04 | 10.77 |
| 2025-07-03 | 10.85 |
| 2025-07-02 | 10.94 |
| 2025-07-01 | 10.80 |
| 2025-06-30 | 10.77 |
| 2025-06-27 | 10.70 |
| 2025-06-26 | 10.75 |
| 2025-06-25 | 10.70 |
| 2025-06-24 | 10.70 |
| 2025-06-23 | 10.39 |
| 2025-06-20 | 10.51 |
| 2025-06-19 | 10.51 |
| 2025-06-18 | 10.65 |
| 2025-06-17 | 10.68 |
| 2025-06-16 | 10.75 |
| 2025-06-13 | 10.63 |
| 2025-06-12 | 10.87 |
| 2025-06-11 | 10.80 |
| 2025-06-10 | 11.33 |
| 2025-06-09 | 11.41 |
| 2025-06-06 | 11.53 |
| 2025-06-05 | 11.50 |
| 2025-06-04 | 11.48 |
| 2025-06-03 | 11.48 |
| 2025-06-02 | 11.33 |
| 2025-05-29 | 11.41 |
| 2025-05-28 | 11.41 |
| 2025-05-27 | 11.43 |
| 2025-05-26 | 11.02 |
| 2025-05-23 | 11.04 |
| 2025-05-22 | 11.02 |
| 2025-05-21 | 11.21 |
| 2025-05-20 | 10.99 |
| 2025-05-19 | 10.92 |
| 2025-05-16 | 10.94 |
| 2025-05-15 | 10.92 |
| 2025-05-14 | 11.04 |
| 2025-05-13 | 10.85 |
| 2025-05-12 | 11.24 |
| 2025-05-09 | 11.14 |
| 2025-05-08 | 11.16 |
| 2025-05-07 | 10.94 |
| 2025-05-06 | 11.02 |
| 2025-05-05 | 10.87 |
| 2025-05-02 | 11.07 |
| 2025-04-30 | 10.68 |